KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Charles River Laboratories International (CRL) Capital Leases (2016 - 2018)

Charles River Laboratories International (CRL) has 9 years of Capital Leases data on record, last reported at $29.2 million in Q4 2018.

  • For Q4 2018, Capital Leases fell 3.5% year-over-year to $29.2 million; the TTM value through Dec 2018 reached $29.2 million, down 3.5%, while the annual FY2018 figure was $29.2 million, 3.5% down from the prior year.
  • Capital Leases reached $29.2 million in Q4 2018 per CRL's latest filing, down from $30.8 million in the prior quarter.
  • Across five years, Capital Leases topped out at $35.8 million in Q2 2015 and bottomed at $717000.0 in Q1 2014.
  • Average Capital Leases over 5 years is $24.4 million, with a median of $29.9 million recorded in 2016.
  • Peak YoY movement for Capital Leases: skyrocketed 3428.59% in 2015, then fell 11.01% in 2016.
  • A 5-year view of Capital Leases shows it stood at $1.0 million in 2014, then soared by 3260.0% to $33.6 million in 2015, then decreased by 11.01% to $29.9 million in 2016, then increased by 1.34% to $30.3 million in 2017, then decreased by 3.5% to $29.2 million in 2018.
  • Per Business Quant database, its latest 3 readings for Capital Leases were $29.2 million in Q4 2018, $30.8 million in Q3 2018, and $30.6 million in Q2 2018.